Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-05 00:00:00 ET · period of report 2023-12-01 · accession 0001048477-23-000049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-05 | 2023-04-28+ | BMRN | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $1.17 | +18.1K | 194.3K | +10% | +$21.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | A | A | 317 | $66.88 | 176,504 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2023-12-01 | A | A | 17,750 | $0.00 | 194,254 | D | — | — | (F2) Restricted stock units granted on December 1, 2023. Price not applicable. |